Bavarian Nordic A/S - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BVNRY Over the counter 2834 www.bavarian-nordic.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bavarian Nordic A/S

Bavarian Nordic AS (BVNKF) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - May 12th, 2025 1:00 pm
Undiscovered European Gems Including 3 Promising Small Caps - May 12th, 2025 10:33 am
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such - May 9th, 2025 3:30 pm
Bavarian Nordic shares rise 7% following strong Q1 for vaccine sales - May 9th, 2025 11:55 am
Bavarian Nordic Announces Interim Results for the First Three Months of 2025 - May 9th, 2025 5:38 am
UPDATE - International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025 - May 8th, 2025 2:44 pm
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025 - May 8th, 2025 12:35 pm
US government exercises $144m option for smallpox/mpox vaccine contract - May 6th, 2025 12:11 pm
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox/Mpox Vaccines - May 6th, 2025 6:56 am
MHRA authorises Bavarian Nordic’s chikungunya virus vaccine - May 2nd, 2025 2:54 pm
Bavarian Nordic Receives Marketing Authorization for Chikungunya Vaccine for Persons Aged 12 and Older in the United Kingdom - May 2nd, 2025 6:30 am
Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP) - Apr 16th, 2025 8:04 pm
Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S - Apr 9th, 2025 4:02 pm
Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S - Apr 9th, 2025 3:38 pm
FDA approves Bavarian Nordic’s freeze-dried mpox and smallpox vaccine - Apr 1st, 2025 1:59 pm
Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine - Mar 31st, 2025 8:38 pm
Bavarian Nordic A/S – Notice Convening Annual General Meeting - Mar 12th, 2025 11:00 am
Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older - Mar 7th, 2025 6:30 am
Bavarian Nordic AS (BVNKF) Q4 2024 Earnings Call Highlights: Strong Vaccine Growth and ... - Mar 6th, 2025 7:05 am
Bavarian Nordic Publishes Annual Report 2024 - Mar 5th, 2025 6:50 am